Slovakia – Medicinal products for the alimentary tract and metabolism – Alfa-alglukozidáza
awardedDetská fakultná nemocnica Košice · 00606715
Description
Liek je potrebný na liečbu pacientov s Pompeho chorobou, ktorí majú nízke hladiny enzýmu nazývaného alfa glukozidáza, ktorý pomáha organizmu regulovať hladiny glykogénu. Glykogén dodáva organizmu energiu, avšak pri Pompeho chorobe sa úrovne glykogénu môžu zvýšiť priveľmi. Liek obsahuje syntetický enzým (účinnú látku) nazývaný alfa-alglukozidáza – dokáže nahradiť prírodný enzým, ktorého je pri Pompeho chorobe nedostatok.
Key facts
- Procedure
- open
- Framework agreement
- Yes — a framework or dynamic purchasing system, not a single contract
- Contact
- obstaravanie@dfnkosice.sk
- Pre-award estimate
- €551k
- Framework ceiling
- €551k
- Regime
- publicSector
- Contract references
- 146/2026
- Category
- supplies
Awarded suppliers
Supplier location as published: Bojnice, SK022, 97201, SK
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 749214-2026
- First seen
- 29 Oct 2026
- Last updated
- 29 Oct 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
GET /api/v1/tenders/200fabf1-3e36-4fa9-b803-eaa741c71763The source notice is authoritative — verify deadlines and documents there before bidding.